DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is ...
Zacks Investment Research on MSN
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now
DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by a huge potential in the CGM market. A strong ...
DexCom is down 2.6% since the beginning of the year, and at $76.47 per share, it is trading 15.7% below its 52-week high of $90.75 from February 2025. Investors who bought $1,000 worth of DexCom’s ...
DexCom (DXCM) shares are in the spotlight after the company delivered better-than-expected second quarter revenues. However, a softer full-year outlook has drawn investor caution. Sector-wide trade ...
The new AI-powered Smart Food Logging feature supports greater personalized insights into how meals are impacting glucose levels Users can now take a photo of their food in their Stelo or Dexcom G7 ...
A software defect could cause the app to terminate, resulting in missed alerts or alarms. Dexcom required users to update the ...
This healthcare technology company is disrupting the diabetes market with innovative technologies that patients love. More than 34 million Americans have diabetes and an additional 88 million are at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback